Search
Stevanato Group SpA
STVNAdd to Watchlist
19.010USD
+0.670+3.65%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
5.75BMarket Cap
42.41P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+3.65%
5 Days
+3.37%
1 Month
+1.17%
6 Months
-7.63%
Year to Date
-5.52%
1 Year
-22.34%
Key Figures
18.750Open
19.010High
336.54KVolume
42.41P/E TTM
22.75P/E Dynamic
0.047Dividend TTM
0.12%Turnover Ratio
18.340Prev. Close
18.733Low
2.63MTurnover
44.06P/E Static
3.00P/B
0.25%Div Yield TTM
5.76%ROA
28.00052wk High
2.26Volume Ratio
117.78MNet Profit
273.00MShares
0.4483EPS TTM
0.77Beta
9.59%ROE
12.89052wk Low
1.51%Amplitude
28.17%Gross Margin
5.75BMarket Cap
-0.35Reward/Risk
2.91%Risk Rate
TradingKey Stock Score of Stevanato Group SpA
Currency: USD Updated: 2026-07-02Key Insights
Stevanato Group SpA's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 16 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 25.18.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Stevanato Group SpA's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Stevanato Group SpA Highlights
StrengthsRisks
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 39.18% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.38B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 12.27%.
Undervalued
The company’s latest PE is 42.39, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 49.73M shares, decreasing 27.47% quarter-over-quarter.
Held by Chuck Royce
Star Investor Chuck Royce holds 640.29K shares of this stock.
Analyst Rating
Based on
12
analysts
Buy
Current Rating
25.175
Target Price
+45.02%
Upside Space
Stevanato Group SpA News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Stevanato Group SpA Info
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
Ticker SymbolSTVN
CompanyStevanato Group SpA
CEOStevanato (Franco)
Websitehttps://www.stevanatogroup.com/
Related Instruments
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+3.50%
+2.59%
-3.06%
+3.76%
+3.40%
+1.10%
+0.28%Popular Instruments
52799.700
-42.800 (-0.08%)
29632.600
+321.200 (+1.10%)
7498.600
+27.100 (+0.36%)
14958.000
+155.000 (+1.05%)
69496.000
+1348.000 (+1.98%)
6379.500
+26.700 (+0.42%)
68.613
+0.269 (+0.39%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4175.100
+53.190 (+1.29%)
FAQs
What is the current price of Stevanato Group SpA (STVN)?
The current price of Stevanato Group SpA (STVN) is 19.01.
What is the symbol of Stevanato Group SpA?
The ticker symbol of Stevanato Group SpA is STVN.
What is the 52-week high of Stevanato Group SpA?
The 52-week high of Stevanato Group SpA is 28.00.
What is the 52-week low of Stevanato Group SpA?
The 52-week low of Stevanato Group SpA is 12.89.
What is the market capitalization of Stevanato Group SpA?
The market capitalization of Stevanato Group SpA is 5.19B.
Is Stevanato Group SpA (STVN) currently rated as Buy, Hold, or Sell?
According to analysts, Stevanato Group SpA (STVN) has an overall rating of Buy, with a price target of 25.18.
What is the Earnings Per Share (EPS TTM) of Stevanato Group SpA (STVN)?
The Earnings Per Share (EPS TTM) of Stevanato Group SpA (STVN) is 0.60.